Bulk Orders 20+ bottles
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Follicle Research
KY-19382, also written KY19382, is a small molecule studied in Wnt/beta-catenin signaling and hair follicle models. This listing is a liquid research solution labeled 5 mg/mL in a 30 mL bottle.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three bottles and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkShipping batch KY01
Open the certificate matched to this shipping batch.
Verified test results
Each batch is analyzed by ILS Laboratories, an independent ISO/IEC 17025 accredited lab, before release. Below is the report for lot KY01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Liquid research preparation
KY-19382, also written KY19382, is a small molecule studied in Wnt/beta-catenin signaling and hair follicle models. This listing is a liquid research solution labeled 5 mg/mL in a 30 mL bottle.
| Compound | KY-19382 (KY19382) |
|---|---|
| Labeled concentration | 5 mg/mL |
| Bottle volume | 30 mL |
| Calculated labeled total | 150 mg |
| Format | Liquid research solution |
KY-19382 is an indirubin-derived small molecule. Research has investigated its effects on Wnt/beta-catenin signaling through CXXC5-Dishevelled interaction and GSK-3 beta inhibition.
No. KY-19382 is a small molecule, although it can appear alongside peptides in a research catalog. Use the full compound identity when selecting literature and analytical methods.
Ryu and colleagues studied human dermal papilla cells, cultured follicles and mouse models. Those preclinical systems provide mechanistic evidence; they do not establish a human hair-growth claim for this research solution.
No. KY-19382 is associated with Wnt signaling research. RU58841 is studied as an androgen receptor antagonist. The RU58841 and Minoxidil blend is also a different formulation with two components.
Ryu et al., 2021: KY19382 preclinical follicle study. See the KY19382 evidence guide and Follicle Research collection.
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Studied Wnt/beta-catenin signaling and follicle responses. The study does not demonstrate a clinical outcome from this research solution.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
Concentration is the stated amount per mL; total content also depends on the container volume. A per-spray amount requires a verified pump output and must not be inferred from concentration alone. Check each component separately for a blend.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
A synthetic small molecule, not a peptide: 5,6-dichloroindirubin-3′-methoxime, written KY19382 in papers, C₁₇H₁₁Cl₂N₃O₂ at 360.2 g/mol in PubChem. In a 2019 paper, a Yonsei University group in Seoul reported selecting it from 60 newly synthesized indirubin derivatives tested against the CXXC5-Dishevelled interaction and GSK-3β kinase activity.
Through two actions its developers measured in cell-free assays: it blocked CXXC5, a negative regulator of Wnt/β-catenin signaling, from binding Dishevelled (IC50 19 nM) and inhibited the kinase GSK-3β (IC50 10 nM); in mouse ATDC5 chondrogenic cells it raised β-catenin. In human cutaneous squamous cell carcinoma cells, by contrast, it inhibited Wnt/β-catenin signaling.
All preclinical. Across the 11 PubMed records that name KY19382 (searched 15 October 2026), the models are cell-free assays, human dermal papilla, skin and endothelial cells, cancer cell lines, a mouse chondrogenic cell line, cultured hair follicles, formulation tests, and mouse hair-follicle, wound, growth-plate and skin-tumor models. None reports giving it to people; Drugs@FDA lists no KY19382 product.
This page lists KY-19382 as a liquid research solution supplied at 5MG/ML in a 30ML bottle, providing 150MG total KY-19382 content. It is sold exclusively for laboratory research purposes, not for human, veterinary, or food use, and ships from the US West Coast, by FedEx 2-Day shipping.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy